
Nephros NEPH
$ 3.19
-1.82%
Quarterly report 2026-Q1
added 05-07-2026
Nephros Depreciation & Amortization 2011-2026 | NEPH
Annual Depreciation & Amortization Nephros
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 140 K | 135 K | 214 K | 218 K | 192 K | 192 K | 186 K | 163 K | 218 K | 19 K | 1 K | 6 K | 9 K | 151 K | 91 K | 129 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 218 K | 1 K | 129 K |
Quarterly Depreciation & Amortization Nephros
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 K | 34 K | 35 K | 39 K | - | 34 K | 34 K | 33 K | - | 55 K | 54 K | 54 K | - | 48 K | 51 K | 51 K | - | 49 K | 51 K | 50 K | - | 49 K | 47 K | 46 K | - | 44 K | 48 K | 50 K | - | 42 K | 40 K | 41 K | - | 60 K | 60 K | 59 K | - | 60 K | 56 K | 55 K | - | 53 K | 53 K | 53 K | - | 54 K | 55 K | 2 K | - | 55 K | 5 K | 2 K | - | 6 K | 5 K | 2 K | - | 23 K | 24 K | 24 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 60 K | 2 K | 40.7 K |
Depreciation & Amortization of other stocks in the Medical instruments industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
15.1 K | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
377 M | $ 68.58 | -0.06 % | $ 13.7 B | ||
|
Glaukos Corporation
GKOS
|
38.1 M | $ 124.9 | -1.21 % | $ 7.14 B | ||
|
Intuitive Surgical
ISRG
|
600 M | $ 425.07 | -0.36 % | $ 152 B | ||
|
ICU Medical
ICUI
|
201 M | $ 144.38 | 1.68 % | $ 3.56 B | ||
|
Repro Med Systems
KRMD
|
810 K | $ 4.03 | 0.75 % | $ 186 M | ||
|
iRhythm Technologies
IRTC
|
20.7 M | $ 116.7 | 2.52 % | $ 3.73 B | ||
|
LeMaitre Vascular
LMAT
|
10.4 M | $ 97.43 | 0.87 % | $ 2.21 B | ||
|
Masimo Corporation
MASI
|
103 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
47 K | $ 1.83 | 0.77 % | $ 83.8 M | ||
|
Ekso Bionics Holdings
EKSO
|
1.57 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
78.2 K | $ 0.39 | -0.31 % | $ 32 M | ||
|
Merit Medical Systems
MMSI
|
123 M | $ 67.96 | 0.67 % | $ 4.02 B | ||
|
electroCore
ECOR
|
501 K | $ 9.52 | - | $ 80.8 K | ||
|
Envista Holdings Corporation
NVST
|
116 M | $ 24.48 | -0.45 % | $ 4.11 B | ||
|
Haemonetics Corporation
HAE
|
112 M | $ 79.66 | 1.17 % | $ 3.76 B | ||
|
STERIS plc
STE
|
486 M | $ 212.15 | -0.28 % | $ 20.8 B | ||
|
Isoray
ISR
|
3.25 M | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
8.32 M | $ 29.97 | 0.33 % | $ 1.49 B | ||
|
InfuSystem Holdings
INFU
|
13.3 M | $ 9.03 | 0.22 % | $ 187 M | ||
|
Teleflex Incorporated
TFX
|
178 M | $ 134.56 | -0.88 % | $ 6 B | ||
|
Utah Medical Products
UTMD
|
826 K | $ 68.07 | - | $ 221 M | ||
|
West Pharmaceutical Services
WST
|
171 M | $ 332.82 | -0.63 % | $ 24.1 B | ||
|
Pulse Biosciences
PLSE
|
406 K | $ 25.25 | -2.04 % | $ 1.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
352 M | $ 10.45 | -0.19 % | $ 2.08 B | ||
|
Retractable Technologies
RVP
|
7.77 M | $ 0.69 | -0.03 % | $ 20.7 M | ||
|
Pro-Dex
PDEX
|
1.24 M | $ 65.09 | 0.14 % | $ 214 M | ||
|
Predictive Oncology
POAI
|
129 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
2.25 M | $ 28.02 | 1.71 % | $ 1.34 B | ||
|
Stereotaxis
STXS
|
626 K | $ 1.83 | -1.08 % | $ 166 M | ||
|
Baxter International
BAX
|
981 M | $ 20.34 | 1.55 % | $ 10.4 B | ||
|
ResMed
RMD
|
160 M | $ 196.36 | -0.32 % | $ 28.7 B | ||
|
AtriCure
ATRC
|
12.1 M | $ 27.78 | 1.74 % | $ 1.33 B | ||
|
Harvard Bioscience
HBIO
|
1.74 M | $ 6.15 | 1.82 % | $ 273 M | ||
|
NeuroMetrix
NURO
|
94 K | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
25.8 M | $ 12.46 | 0.97 % | $ 509 M | ||
|
Becton, Dickinson and Company
BDX
|
2.46 B | $ 151.46 | -0.39 % | $ 43.6 B | ||
|
OraSure Technologies
OSUR
|
10.2 M | $ 4.27 | 0.71 % | $ 314 M | ||
|
Repligen Corporation
RGEN
|
78.7 M | $ 133.39 | 2.51 % | $ 7.5 M |